Invention Grant
- Patent Title: Administration and monitoring of nitric oxide in ex vivo fluids
-
Application No.: US15493578Application Date: 2017-04-21
-
Publication No.: US11291202B2Publication Date: 2022-04-05
- Inventor: Jim Potenziano , Douglas R. Hansell , Jeff Griebel , Eddie Costa , Lisa Cooper , David William Newman
- Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
- Applicant Address: IE Dublin
- Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
- Current Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
- Current Assignee Address: IE Dublin
- Main IPC: A01N1/02
- IPC: A01N1/02 ; C12N5/078 ; A61M1/14 ; A61L15/16 ; A61P43/00 ; A61K33/06 ; A61K33/24 ; A61P9/08 ; A61K31/74 ; C12N5/00 ; A61P9/10 ; A61P7/02 ; A61M15/00 ; A61M16/00

Abstract:
Described are systems and methods for monitoring administration of nitric oxide (NO) to ex vivo fluids. Examples of such fluids include blood in extracorporeal membrane oxygenation (ECMO) circuits or perfusion fluids used for preserving ex vivo organs prior to transplanting in a recipient. The systems and methods described herein provide for administering nitric oxide to the fluid, monitoring nitric oxide or a nitric oxide marker in the fluid, and adjusting the nitric oxide administration.
Public/Granted literature
- US20170215411A1 ADMINISTRATION AND MONITORING OF NITRIC OXIDE IN EX VIVO FLUIDS Public/Granted day:2017-08-03
Information query